Free Trial
OTCMKTS:SIGY

Sigyn Therapeutics (SIGY) Stock Price, News & Analysis

Sigyn Therapeutics logo
$3.53 -0.62 (-14.94%)
As of 04/25/2025 12:35 PM Eastern

About Sigyn Therapeutics Stock (OTCMKTS:SIGY)

Key Stats

Today's Range
$3.50
$3.53
50-Day Range
$3.53
$4.49
52-Week Range
$3.15
$6.34
Volume
300 shs
Average Volume
436 shs
Market Capitalization
$5.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.

Receive SIGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigyn Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SIGY Stock News Headlines

Sigyn Therapeutics Delays Yearly Report Filing
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
See More Headlines

SIGY Stock Analysis - Frequently Asked Questions

Sigyn Therapeutics' stock was trading at $3.15 on January 1st, 2025. Since then, SIGY stock has increased by 12.1% and is now trading at $3.53.
View the best growth stocks for 2025 here
.

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) announced its earnings results on Tuesday, April, 15th. The company reported ($2.51) earnings per share (EPS) for the quarter.

Shares of SIGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sigyn Therapeutics investors own include Rocket Lab USA (RKLB), Archer Aviation (ACHR), Atlas Lithium (ATLX), OriginClear (OCLN), Boxed (BOXD), bluebird bio (BLUE) and BlackSky Technology (BKSY).

Company Calendar

Last Earnings
4/15/2025
Today
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:SIGY
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,150,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.80) per share
Price / Book
-1.26

Miscellaneous

Free Float
346,000
Market Cap
$5.67 million
Optionable
Not Optionable
Beta
-1.04
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:SIGY) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners